Select Page

South Delhi Pharma, New Delhi, India

OPDIVO (nivolumab) injection, for intravenous use.

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call 9891296838 or Email query@southdelhipharma.com to discuss.

OPDIVO is a prescription medicine for small cell lung cancer (SCLC) treatment.
INDICATIONS AND USAGE
OPDIVO is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of:
Melanoma, Non-Small Cell Lung Cancer (NSCLC), Malignant Pleural Mesothelioma, Renal Cell Carcinoma (RCC)
Classical Hodgkin Lymphoma (cHL), Colorectal Cancer, Hepatocellular Carcinoma (HCC), Esophageal Squamous Cell Carcinoma (ESCC).
DOSAGE FORMS & STRENGTHS
Injection: 40 mg/4 mL, 100 mg/10 mL, and 240 mg/24 mL solution in a single-dose vial.
Manufactured By: Bristol-Myers Squibb.
Prescribing Information URL: Click Here

South Delhi Pharma can facilitate the supply of “OPDIVO (nivolumab) injection” to all locations in India and other part of countries after fulfilling the legal requirement (if applicable). All Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from South Delhi Pharma.

Category:

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

8 + 6 =

Nivolumab, sold under the brand name Opdivo, is a medication used to treat a number of types of cancer. This includes melanoma, lung cancer, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, colon cancer, and liver cancer. It is used by slow injection into a vein.[

Nivolumab was approved for medical use in the United States in 2014. It is on the World Health Organization's List of Essential Medicines. It is made using Chinese hamster ovary cells.

Reviews

There are no reviews yet.

Be the first to review “OPDIVO (nivolumab) injection, for intravenous use.”

Your email address will not be published.